RE:How do psychedelic companies make money? Number 1 is really the only blockbuster moneymaker in the space, but you're thinking about it all wrong, especially by comparing to marijuana.
The big play here is pharmaceutical. Whereas the big play for weed was recreational. For the most part, at least to start in the next 5+ years, these drugs will predominantly be used in a clinical setting. Many of these drugs/therapies will be covered by health insurance and benefits, where there would be no need for someone to go buy unsafe products from the grey/black market. Where would you rather buy/take these drugs? Clinical setting/covered by insurance? Or off the street and take the risk?
If you're thinking there will be Recreational psychedelics - those are a longggggg way off, which is the big difference between this and weed.
Jiminee wrote: I see three types of activities and some companies will have all three.
1) growing, producing, manufacturing drugs
2) psychotherapy services accompanying use of drugs
3) associated services, eg media, patient management, etc.
(1) I know drugs are being patented, but how different will these drugs --- even if they are synthesized -- be from what can be bought on the grey market, as now occurs for marijuana which underprices the legal product?
(2) I wonder how profitable these services can be. Also, stand alone psychotherapists, with much lower overheads, could compete directly with these companies.
(3) What kind of companies here will be profitable?
Thankyou for your assistance.